Showing results (881-890 of 5,689) with videos related to

Sort By:
Pageof 569
The Oncologist|March 16, 2016
Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment AlgorithmClaudia I Chapuy, Inderneel Sahai, Rohit Sharma, et al.
The Oncologist|November 24, 2020
Challenges and Opportunities in the Management of Diffuse Large B-Cell Lymphoma in Older PatientsMengyang Di, Scott F Huntington, Adam J Olszewski
The Oncologist|September 4, 2020
FOLFIRINOX De-Escalation in Advanced Pancreatic Cancer: A Multicenter Real-Life StudyHortense Chevalier, Angélique Vienot, Astrid Lièvre, et al.
The Oncologist|September 5, 2020
Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 PandemicJavier Martin-Broto, Nadia Hindi, Samuel Aguiar, et al.
The Oncologist|September 8, 2020
Identification of a Novel EHBP1-MET Fusion in an Intrahepatic Cholangiocarcinoma Responding to CrizotinibYiyi Yu, Qing Liu, Wei Li, et al.
The Oncologist|November 3, 2020
A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular CarcinomaChun A Changou, Her-Shyong Shiah, Li-Tzong Chen, et al.
The Oncologist|November 3, 2020
A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast CancerBora Lim, Juhee Song, Nuhad K Ibrahim, et al.
The Oncologist|June 21, 2022
Unmet Needs in Oncology Clinical Research and Treatment in Africa: Focus on GhanaLewis R Roberts, Brian M Rivers, Clayton C Yates, et al.
The Oncologist|December 28, 2022
Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib TrialJames Larkin, Mototsugu Oya, Marcella Martignoni, et al.
The Oncologist|January 17, 2023
Combining Sunitinib and Bevacizumab for the Management of Advanced Renal Cell Carcinoma: A Phase I/II TrialShouki Bazarbashi, Ahmed Alzahrani, Ali Aljubran, et al.
Pageof 569